This segment focuses on the design, development, manufacturing, and global sales of medical devices and implants used in the treatment of peripheral vascular disease. Research and development activities include the continuous improvement of existing products and the development of new devices, such as angioscopes, embolectomy catheters, occlusion catheters, perfusion catheters, thrombectomy catheters, carotid shunts, radiopaque tape, valvulotomes, and vascular grafts. Technologies employed include advanced materials science, catheter design, and imaging technologies. The therapeutic areas addressed are primarily cardiology and vascular surgery, with the goal of improving patient outcomes by providing minimally invasive and effective treatment options. Market positioning is strong due to a direct sales force and established distribution networks. Future opportunities include expansion into new geographic markets and the development of innovative devices. Regulatory and clinical aspects are critical, with a focus on obtaining and maintaining FDA approval and other international certifications. Partnerships with healthcare providers and distributors are essential for market access and product adoption.

This segment focuses on the development and commercialization of devices and technologies for the management of vascular clots. This includes the acquisition of the vascular clot management business of Applied Medical Resources Corporation. Research and development activities are focused on improving the efficacy and safety of clot removal procedures. Technologies include advanced catheter designs and thrombectomy techniques. The therapeutic area is cardiology and vascular surgery, with the goal of improving patient outcomes by providing minimally invasive and effective treatment options. Market positioning is enhanced through the acquisition of innovative technologies and a focus on unmet clinical needs. Future opportunities include the development of new clot management devices and expansion into new markets. Regulatory and clinical aspects are critical, with a focus on obtaining and maintaining FDA approval and other international certifications. Partnerships with healthcare providers and distributors are essential for market access and product adoption.